(Q39435590)

11 September 2017

Treatment of recurrent ventricular tachycardia and fibrillation with aprindine (English)

1 reference

11 September 2017

ventricular tachycardia

1 reference

1 reference

A F Fasola

1

1 reference

11 September 2017

R J Noble

series ordinal

2

1 reference

11 September 2017

D P Zipes

series ordinal

3

1 reference

11 September 2017

language of work or name

English

0 references

publication date

1 May 1977

1 reference

American Journal of Cardiology

11 September 2017

1 reference

11 September 2017

39

1 reference

11 September 2017

6

1 reference

11 September 2017

903-909

1 reference

Treatment of recurrent symptomatic ventricular tachycardia

11 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2877%2980045-3

Mitral valve prolapse-click syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2877%2980045-3

Therapeutic effectivenss and plasma levels of aprindine, a new antidysrhythmic drug

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2877%2980045-3

Agranulocytosis and aprindine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2877%2980045-3

Intracellular electrophysiological alterations in canine cardiac conducting tissue induced by aprindine and lignocaine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2877%2980045-3

Suppression of ouabain-induced ventricular rhythms with aprindine HCl. A comparison with other antiarrhythmic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2877%2980045-3

Effect of drugs on conduction delay and incidence of ventricular arrhythmias induced by acute coronary occlusion in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2877%2980045-3

10.1016/S0002-9149(77)80045-3

7 January 2021

Identifiers

DOI

1 reference

11 September 2017

1 reference